Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/176046
Title: Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic
Author: Moreno, Raúl
Díez, José Luis
Diarte, José Antonio
Salinas, Pablo
Torre Hernández, José María de la
Andres Cordón, Juan F.
Trillo, Ramiro
Alonso Briales, Juan
Amat Santos, Ignacio
Romaguera, Rafael
Díaz, José Francisco
Vaquerizo, Beatriz
Ojeda, Soledad
Cruz González, Ignacio
Morena Salas, Daniel
Pérez de Prado, Armando
Sarnago, Fernando
Portero, Pilar
Gutierrez Barrios, Alejandro
Alfonso, Fernando
Bosch, Eduard
Pinar, Eduardo
Ruiz Arroyo, José Ramón
Ruiz Quevedo, Valeriano
Jiménez Mazuecos, Jesús
Lozano, Fernando
Rumoroso, José Ramón
Novo, Enrique
Irazusta, Francisco J.
García del Blanco, Bruno
Moreu, José
Ballesteros Pradas, Sara M.
Frutos, Araceli
Villa, Manuel
Alegría Barrero, Eduardo
Lázaro, Rosa
Paredes, Emilio
Keywords: Diabetis
COVID-19
Cardiologia
Mortalitat
Diabetes
COVID-19
Cardiology
Mortality
Issue Date: 23-Mar-2021
Publisher: Springer Nature
Abstract: Background: During COVID-19 pandemic, elective invasive cardiac procedures (ICP) have been frequently cancelled or postponed. Consequences may be more evident in patients with diabetes. Objectives: The objective was to identify the peculiarities of patients with DM among those in whom ICP were cancelled or postponed due to the COVID-19 pandemic, as well as to identify subgroups in which the influence of DM has higher impact on the clinical outcome. Methods: We included 2,158 patients in whom an elective ICP was cancelled or postponed during COVID-19 pandemic in 37 hospitals in Spain. Among them, 700 (32.4%) were diabetics. Patients with and without diabetes were compared. Results: Patients with diabetes were older and had a higher prevalence of other cardiovascular risk factors, previous cardiovascular history and co-morbidities. Diabetics had a higher mortality (3.0% vs. 1.0%; p = 0.001) and cardiovascular mortality (1.9% vs. 0.4%; p = 0.001). Differences were especially important in patients with valvular heart disease (mortality 6.9% vs 1.7% [p < 0.001] and cardiovascular mortality 4.9% vs 0.9% [p = 0.002] in patients with and without diabetes, respectively). In the multivariable analysis, diabetes remained as an independent risk factor both for overall and cardiovascular mortality. No significant interaction was found with other clinical variables. Conclusion: Among patients in whom an elective invasive cardiac procedure is cancelled or postponed during COVID-19 pandemic, mortality and cardiovascular mortality is higher in patients with diabetes, irrespectively on other clinical conditions. These procedures should not be cancelled in patients with diabetes.
Note: Reproducció del document publicat a: https://doi.org/10.1186/s12933-021-01261-2
It is part of: Cardiovascular Diabetology, 2021, vol. 20
URI: http://hdl.handle.net/2445/176046
Related resource: https://doi.org/10.1186/s12933-021-01261-2
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
s12933-021-01261-2.pdf924.53 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons